Mouse RvD1(Resolvin D1) ELISA Kit [ELK0494]_ELK Biotechnology - 코아사이언스
Mouse RvD1(Resolvin D1) ELISA Kit
Cat. # ELK0494 / Size: 48T, 96T
Overview
| Product name: | Mouse RvD1(Resolvin D1) ELISA Kit |
| Reactivity: | Mouse |
| Alternative Names: | RvD1 |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 13.1 pg/mL |
| Standard: | 2000 pg/mL |
| Detection Range: | 31.25-2000 pg/mL |
| Sample Type: | serum, plasma and other biological fluids |
| Assay Length: | 2.5h |
| Research Area: | Immunology & Inflammation |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Mouse RvD1 protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse RvD1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse RvD1 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard Curve
| Concentration (pg/mL) | OD | Corrected OD |
| 2000.00 | 0.185 | |
| 1000.00 | 0.413 | |
| 500.00 | 0.596 | |
| 250.00 | 0.997 | |
| 125.00 | 1.197 | |
| 62.50 | 1.522 | |
| 31.25 | 1.889 | |
| 0.00 | 2.101 |
Precision
Intra-assay Precision (Precision within an assay)：CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays)：CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant RvD1 and the recovery rates were calculated by comparing the measured value to the expected amount of RvD1 in samples.
| Average | Recovery range | Average |
| serum(n=5) | 84-106% | 100% |
| EDTA plasma(n=5) | 87-99% | 93% |
| Heparin plasma(n=5) | 87-93% | 90% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of RvD1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 88-102% | 86-92% | 81-93% | 79-87% |
| EDTA plasma(n=5) | 85-94% | 92-101% | 87-96% | 82-90% |
| Heparin plasma(n=5) | 87-95% | 85-98% | 82-97% | 92-101% |
Citations
| Subject | Time | Magazine | IF | Link |
| Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome | 2024-01-03 | ACS Nano | 17.1 | https://doi.org/10.1021/acsnano.3c09848 |
코아사이언스 coresciences Korea ELK Biotechnology CO.,LTD ELK (Wuhan) Biotechnology CO.,Ltd. 한국 대리점 ELISA antibody 항체 면역학 연구 세포배양 분자생물학 시약